share_log

歌禮製藥-B:翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Mar 5 07:17
Summary by Moomoo AI
歌禮製藥有限公司於2024年3月5日提交了翌日披露報表,披露其已發行股本變動情況。根據報表,公司在2023年12月19日至2024年2月22日期間進行了股份購回並於2024年3月5日註銷了總計32,063,000股。此次股份購回後,歌禮製藥的已發行股本從1,044,821,000股減少至1,012,758,000股。該股份購回行動是根據《香港聯合交易所有限公司證券上市規則》所作的披露。
歌禮製藥有限公司於2024年3月5日提交了翌日披露報表,披露其已發行股本變動情況。根據報表,公司在2023年12月19日至2024年2月22日期間進行了股份購回並於2024年3月5日註銷了總計32,063,000股。此次股份購回後,歌禮製藥的已發行股本從1,044,821,000股減少至1,012,758,000股。該股份購回行動是根據《香港聯合交易所有限公司證券上市規則》所作的披露。
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on March 5, 2024, disclosing the change in its issued share capital. According to the report, the company repurchased shares from December 19, 2023 to February 22, 2024 and wrote off a total of 32,063,000 shares on March 5, 2024. Following this share repurchase, Song Pharmaceutical's issued share capital decreased from 1,044,821,000 shares to 1,012,758,000 shares. The share repurchase is a disclosure made pursuant to the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on March 5, 2024, disclosing the change in its issued share capital. According to the report, the company repurchased shares from December 19, 2023 to February 22, 2024 and wrote off a total of 32,063,000 shares on March 5, 2024. Following this share repurchase, Song Pharmaceutical's issued share capital decreased from 1,044,821,000 shares to 1,012,758,000 shares. The share repurchase is a disclosure made pursuant to the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more